Literature DB >> 34182794

Mapping the Nonstructural Transmembrane Proteins of Severe Acute Respiratory Syndrome Coronavirus 2.

Sunil Thomas1.   

Abstract

Severe acute respiratory syndrome coronavirus 2 (n class="Species">SARS-CoV-2) responsible for the disease coronavirus-19 disease (COVID-19) has wreaked havoc on the health and economy of humanity. In addition, the disease is observed in domestic and wild animals. The disease has impacted directly and indirectly every corner of the planet. Currently, there are no effective therapies for the treatment of COVID-19. Vaccination to protect against COVID-19 started in December 2020. SARS-CoV-2 is an enveloped virus with a single-stranded RNA genome of 29.8 kb. More than two-thirds of the genome comprise Orf1ab encoding 16 nonstructural proteins (nsps) followed by mRNAs encoding structural proteins, spike (S), envelop (E), membrane (M), and nucleocapsid (N). These genes are interspaced with several accessory genes (open reading frames [Orfs] 3a, 3b, 6, 7a, 7b, 8, 9b, 9c, and 10). The functions of these proteins are of particular interest for understanding the pathogenesis of SARS-CoV-2. Several of the nsps (nsp3, nsp4, and nsp6) and Orf3a are transmembrane proteins involved in regulating the host immunity, modifying host cell organelles for viral replication and escape and hence considered drug targets. In this paper, we report mapping the transmembrane structure of the nsps of SARS-CoV-2.

Entities:  

Keywords:  COVID-19; Orf1ab; Orf3a; SARS-CoV-2; coronavirus; double-membrane vesicle; endoplasmic reticulum; nonstructural proteins; nsp3; nsp4; nsp6; nsps

Year:  2021        PMID: 34182794     DOI: 10.1089/cmb.2020.0627

Source DB:  PubMed          Journal:  J Comput Biol        ISSN: 1066-5277            Impact factor:   1.479


  8 in total

1.  Genome Profiling of SARS-CoV-2 in Indonesia, ASEAN and the Neighbouring East Asian Countries: Features, Challenges and Achievements.

Authors:  Inswasti Cahyani; Eko W Putro; Asep M Ridwanuloh; Satrio Wibowo; Hariyatun Hariyatun; Gita Syahputra; Gilang Akbariani; Ahmad R Utomo; Mohammad Ilyas; Matthew Loose; Wien Kusharyoto; Susanti Susanti
Journal:  Viruses       Date:  2022-04-08       Impact factor: 5.818

Review 2.  Structural biology of SARS-CoV-2: open the door for novel therapies.

Authors:  Weizhu Yan; Yanhui Zheng; Xiaotao Zeng; Bin He; Wei Cheng
Journal:  Signal Transduct Target Ther       Date:  2022-01-27

3.  Immunoinformatics Analysis of SARS-CoV-2 ORF1ab Polyproteins to Identify Promiscuous and Highly Conserved T-Cell Epitopes to Formulate Vaccine for Indonesia and the World Population.

Authors:  Marsia Gustiananda; Bobby Prabowo Sulistyo; David Agustriawan; Sita Andarini
Journal:  Vaccines (Basel)       Date:  2021-12-09

4.  Omicron BA.2 lineage spreads in clusters and is concentrated in Denmark.

Authors:  Perumal A Desingu; K Nagarajan
Journal:  J Med Virol       Date:  2022-02-21       Impact factor: 20.693

Review 5.  SARS-CoV-2 and the Nucleus.

Authors:  Mengqi Chen; Yue Ma; Wakam Chang
Journal:  Int J Biol Sci       Date:  2022-07-11       Impact factor: 10.750

Review 6.  Cytokines and microRNAs in SARS-CoV-2: What do we know?

Authors:  Fahimeh Zamani Rarani; Bahman Rashidi; Mohammad Hassan Jafari Najaf Abadi; Michael R Hamblin; Seyed Mohammad Reza Hashemian; Hamed Mirzaei
Journal:  Mol Ther Nucleic Acids       Date:  2022-06-25       Impact factor: 10.183

Review 7.  SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion.

Authors:  Zheng Yao Low; Nur Zawanah Zabidi; Ashley Jia Wen Yip; Ashwini Puniyamurti; Vincent T K Chow; Sunil K Lal
Journal:  Viruses       Date:  2022-09-08       Impact factor: 5.818

Review 8.  Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19.

Authors:  Can-Rong Wu; Wan-Chao Yin; Yi Jiang; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2022-01-20       Impact factor: 7.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.